- Home
- RNXT vs LTRN Comparison
RNXT vs LTRN Comparison
Compare RNXT & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- LTRN
- Stock Information
- Founded
- RNXT 2012
- LTRN 2013
- Country
- RNXT United States
- LTRN United States
- Employees
- RNXT N/A
- LTRN N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- RNXT Health Care
- LTRN Health Care
- Exchange
- RNXT Nasdaq
- LTRN Nasdaq
- Market Cap
- RNXT 31.6M
- LTRN 33.7M
- IPO Year
- RNXT 2021
- LTRN 2020
- Fundamental
- Price
- RNXT $1.14
- LTRN $4.99
- Analyst Decision
- RNXT Strong Buy
- LTRN Hold
- Analyst Count
- RNXT 1
- LTRN 1
- Target Price
- RNXT $9.00
- LTRN N/A
- AVG Volume (30 Days)
- RNXT 195.7K
- LTRN 157.2K
- Earning Date
- RNXT 03-31-2025
- LTRN 03-17-2025
- Dividend Yield
- RNXT N/A
- LTRN N/A
- EPS Growth
- RNXT N/A
- LTRN N/A
- EPS
- RNXT N/A
- LTRN N/A
- Revenue
- RNXT N/A
- LTRN N/A
- Revenue This Year
- RNXT N/A
- LTRN N/A
- Revenue Next Year
- RNXT N/A
- LTRN N/A
- P/E Ratio
- RNXT N/A
- LTRN N/A
- Revenue Growth
- RNXT N/A
- LTRN N/A
- 52 Week Low
- RNXT $0.77
- LTRN $2.79
- 52 Week High
- RNXT $1.86
- LTRN $11.99
- Technical
- Relative Strength Index (RSI)
- RNXT 36.31
- LTRN 64.21
- Support Level
- RNXT $1.09
- LTRN $4.60
- Resistance Level
- RNXT $1.40
- LTRN $5.30
- Average True Range (ATR)
- RNXT 0.10
- LTRN 0.61
- MACD
- RNXT -0.03
- LTRN 0.06
- Stochastic Oscillator
- RNXT 8.51
- LTRN 68.99
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.